Home » Stocks » Repro-Med Systems

Repro-Med Systems, Inc. (KRMD)

Stock Price: $6.43 USD 0.04 (0.63%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed
After-hours: $6.45 +0.02 (0.31%) Oct 21, 5:06 PM

Stock Price Chart

Key Info

Market Cap 282.34M
Revenue (ttm) 26.88M
Net Income (ttm) -55,054
Shares Out 43.91M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE 49.75
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 21, 2020
Last Price $6.43
Previous Close $6.39
Change ($) 0.04
Change (%) 0.63%
Day's Open 6.38
Day's Range 6.11 - 6.45
Day's Volume 262,742
52-Week Range 6.11 - 12.23

More Stats

Market Cap 282.34M
Enterprise Value 248.02M
Earnings Date (est) Dec 16, 2020
Ex-Dividend Date n/a
Shares Outstanding 43.91M
Float 39.43M
EPS (basic) -0.01
EPS (diluted) -0.01
FCF / Share 0.10
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 1.42%
Payout Ratio n/a
Shares Short 1.33M
Short Ratio 4.33
Short % of Float 3.37%
Beta 0.30
PE Ratio n/a
Forward PE 49.75
P/FCF Ratio 70.33
PS Ratio 10.50
PB Ratio 7.51
Revenue 26.88M
Operating Income 215,662
Net Income -55,054
Free Cash Flow 4.01M
Net Cash 34.32M
Net Cash / Share 0.78
Gross Margin 55.26%
Operating Margin 0.80%
Profit Margin -0.20%
FCF Margin 14.93%
ROA 9.54%
ROE -0.23%
ROIC 4.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$14.00*
(117.73% upside)
Low
13.0
Current: $6.43
High
16.0
Target: 14.00
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820162015201420132012201120102009
Revenue23.1617.3512.2912.2511.248.707.766.394.923.77
Revenue Growth33.47%41.16%0.38%8.92%29.27%12.04%21.49%29.87%30.35%-
Gross Profit14.8510.817.577.606.695.314.944.143.262.51
Operating Income0.591.16-0.741.181.151.011.061.291.190.72
Net Income0.560.91-0.530.780.750.700.730.820.700.89
Shares Outstanding38.7838.1337.8337.9937.6336.6636.0134.2536.2435.38
Earnings Per Share0.010.02-0.010.020.020.020.020.020.020.02
EPS Growth-50%--0%0%0%0%0%0%-
Operating Cash Flow0.321.48-0.331.910.830.950.780.561.030.38
Capital Expenditures0.02-0.29-0.20-0.11-0.59-0.19-0.56-0.24-0.20-0.05
Free Cash Flow0.341.19-0.531.810.230.770.220.320.830.33
Cash & Equivalents5.875.26-4.462.822.492.192.011.470.81
Total Debt0.38-----0.440.480.520.69
Net Cash / Debt5.495.26-4.462.822.491.751.530.950.12
Assets13.8810.55-8.397.286.215.594.813.432.99
Liabilities2.651.58-1.281.011.021.241.250.951.30
Book Value11.248.96-7.126.275.194.363.552.481.69
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Repro-Med Systems, Inc.
Country United States
Employees 71
CEO Donald B. Pettigrew

Stock Information

Ticker Symbol KRMD
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: KRMD

Description

Repro Med Systems, doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.